However, high POPDC3 expression has also been correlated to poor clinical prognosis in head and neck squamous cell carcinoma, suggesting that POPDC3 potentially plays different roles in the progression of different types of cancer. This evidence concerns the gene POPDC3 and head and neck squamous cell carcinoma.